Medicare's final rule strengthens oversight of accrediting organizations by addressing conflicts of interest, establishing consistent standards, and updating validation systems for deemed providers and suppliers across multiple care settings.
Proposed rule codifies Medicare Drug Price Negotiation Program under the Inflation Reduction Act of 2022 and establishes new policies for drug benefit programs and fixed combination drugs.
National Institute of Diabetes and Digestive and Kidney Diseases announces an amended meeting notice for its advisory council to discuss research priorities and funding initiatives affecting small biotech and life-sciences firms.
Center for Scientific Review announces amended open meeting schedule to discuss peer review processes and grant evaluation procedures for National Institutes of Health funding cycles.
Center for Scientific Review amends meeting notice regarding review panels and grant evaluation procedures for National Institutes of Health funding decisions.
National Institute on Aging offers licensing opportunities for fluorophthalimide compounds in development as anti-inflammatory therapeutics for systemic and neurodegenerative disorders.
National Institute on Aging offers licensing opportunities for 4-amino-2-(piperidin-3-yl)isoindoline-1,3-diones, pre-clinical anti-inflammatory compounds targeting systemic and neurodegenerative disorders, to qualified research and commercialization…
OFAC adds individuals to the Specially Designated Nationals and Blocked Persons List, requiring U.S. persons to block all property and transactions involving these designated parties.
Center for Scientific Review will hold closed National Institutes of Health review meetings to evaluate grant applications across multiple scientific disciplines during specified dates in 2024 and 2025.
National Institute of Biomedical Imaging and Bioengineering announces a public meeting to discuss research funding priorities and grant opportunities for biomedical imaging and bioengineering projects.
Tell Bizmoon what your business does and we'll cut the Federal Register down to what actually matters.
Every rule is broken into specific to-dos with calendar dates.
We tell you which parts of your business each rule actually touches.
After healthcare come the capital-heavy sectors: trade, transportation, energy, and finance. If you operate in one of them, the volume of change is relentless.
No legal jargon. Read the impact in two sentences.
Email + dashboard pings the moment something changes.
